166 related articles for article (PubMed ID: 12955086)
1. Cytoplasmic c-Abl provides a molecular 'Rheostat' controlling carcinoma cell survival and invasion.
Kain KH; Gooch S; Klemke RL
Oncogene; 2003 Sep; 22(38):6071-80. PubMed ID: 12955086
[TBL] [Abstract][Full Text] [Related]
2. Proapoptotic function of the nuclear Crk II adaptor protein.
Kar B; Reichman CT; Singh S; O'Connor JP; Birge RB
Biochemistry; 2007 Sep; 46(38):10828-40. PubMed ID: 17764157
[TBL] [Abstract][Full Text] [Related]
3. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
Jung JH; Pendergast AM; Zipfel PA; Traugh JA
Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
[TBL] [Abstract][Full Text] [Related]
5. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
Noren NK; Foos G; Hauser CA; Pasquale EB
Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
[TBL] [Abstract][Full Text] [Related]
6. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage.
Yoshida K; Yamaguchi T; Natsume T; Kufe D; Miki Y
Nat Cell Biol; 2005 Mar; 7(3):278-85. PubMed ID: 15696159
[TBL] [Abstract][Full Text] [Related]
7. Src regulates phorbol 12-myristate 13-acetate-activated PKC-induced migration via Cas/Crk/Rac1 signaling pathway in glioblastoma cells.
Nomura N; Nomura M; Sugiyama K; Hamada J
Int J Mol Med; 2007 Oct; 20(4):511-9. PubMed ID: 17786281
[TBL] [Abstract][Full Text] [Related]
8. Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix.
Cho SY; Klemke RL
J Cell Biol; 2000 Apr; 149(1):223-36. PubMed ID: 10747099
[TBL] [Abstract][Full Text] [Related]
9. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.
Davoodpour P; Landström M; Welsh M
BMC Cancer; 2007 Aug; 7():161. PubMed ID: 17697368
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes.
Kain KH; Klemke RL
J Biol Chem; 2001 May; 276(19):16185-92. PubMed ID: 11279004
[TBL] [Abstract][Full Text] [Related]
11. RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration.
Hu H; Bliss JM; Wang Y; Colicelli J
Curr Biol; 2005 May; 15(9):815-23. PubMed ID: 15886098
[TBL] [Abstract][Full Text] [Related]
12. Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold.
Chodniewicz D; Klemke RL
Biochim Biophys Acta; 2004 Jul; 1692(2-3):63-76. PubMed ID: 15246680
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex.
Payne SL; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2006 Jul; 98(4):827-37. PubMed ID: 16440329
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma.
Kumar S; Lu B; Dixit U; Hossain S; Liu Y; Li J; Hornbeck P; Zheng W; Sowalsky AG; Kotula L; Birge RB
Oncotarget; 2015 Nov; 6(35):37792-807. PubMed ID: 26473374
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of proteasome function induces Abl-mediated cell death by uncoupling p130CAS and c-CrkII.
Holcomb M; Rufini A; Barilà D; Klemke RL
J Biol Chem; 2006 Feb; 281(5):2430-40. PubMed ID: 16267043
[TBL] [Abstract][Full Text] [Related]
17. CAS promotes invasiveness of Src-transformed cells.
Brábek J; Constancio SS; Shin NY; Pozzi A; Weaver AM; Hanks SK
Oncogene; 2004 Sep; 23(44):7406-15. PubMed ID: 15273716
[TBL] [Abstract][Full Text] [Related]
18. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
[TBL] [Abstract][Full Text] [Related]
19. CrkI adapter protein modulates cell migration and invasion in glioblastoma.
Takino T; Nakada M; Miyamori H; Yamashita J; Yamada KM; Sato H
Cancer Res; 2003 May; 63(9):2335-7. PubMed ID: 12727859
[TBL] [Abstract][Full Text] [Related]
20. Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli.
Hägerkvist R; Mokhtari D; Lindholm C; Farnebo F; Mostoslavsky G; Mulligan RC; Welsh N; Welsh M
Exp Cell Res; 2007 Jan; 313(2):284-91. PubMed ID: 17112510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
